593 related articles for article (PubMed ID: 7884017)
1. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
2. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO
Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979
[TBL] [Abstract][Full Text] [Related]
3. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
4. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
5. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
[TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
8. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
9. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
Klieser E; Lehmann E; Tegeler J
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients.
Taymeeyapradit U; Kuasirikul S
J Med Assoc Thai; 2002 Dec; 85(12):1301-8. PubMed ID: 12678168
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of zuclopenthixol acetate compared with injectable haloperidol in schizophrenic patients with acute psychosis.
Laurier C; Kennedy W; Lachaine J; Gariepy L; Tessier G
Clin Ther; 1997; 19(2):316-29. PubMed ID: 9152570
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
13. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
Lapierre YD; Ancill R; Awad G; Bakish D; Beaudry P; Bloom D; Chandrasena R; Das M; Durand C; Elliott D
J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
[TBL] [Abstract][Full Text] [Related]
14. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V
Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of zuclopenthixol acetate on psychotic anxiety evaluated in an open study].
Romain JL; Dermain P; Greslé P; Grignon S; Moisan P; Nore D; Pech G; Benyaya J; Perret I
Encephale; 1996; 22(4):280-6. PubMed ID: 9035983
[TBL] [Abstract][Full Text] [Related]
16. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
[TBL] [Abstract][Full Text] [Related]
17. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
Wistedt B; Koskinen T; Thelander S; Nerdrum T; Pedersen V; Mølbjerg C
Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680
[TBL] [Abstract][Full Text] [Related]
18. A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis.
Baastrup PC; Alhfors UG; Bjerkenstedt L; Dencker SJ; Fensbo C; Gravem A; Pedersen V; Elgen K; Brekke B; Fredslund-Andersen K
Acta Psychiatr Scand; 1993 Jan; 87(1):48-58. PubMed ID: 8093824
[TBL] [Abstract][Full Text] [Related]
19. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
Laux G; Klieser E; Schröder HG; Dittmann V; Unterweger B; Schubert H; König P; Schöny HW; Bunse J; Beckmann H
Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
[TBL] [Abstract][Full Text] [Related]
20. Haloperidol in acute schizophrenic inpatients. A double-blind comparison of two dosage regimens.
Modestin J; Toffler G; Pia M; Greub E
Pharmacopsychiatria; 1983 Jul; 16(4):121-6. PubMed ID: 6356177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
